micro-community-banner
 
  • Saved

Ki67 Proliferation Index in Germinal and Non-Germinal Subtypes of Diffuse Large B-Cell Lymphoma - PubMed

Ki67 Proliferation Index in Germinal and Non-Germinal Subtypes of Diffuse Large B-Cell Lymphoma - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/33728138/

Introduction Diffuse large B-cell lymphoma (DLBCL) is an aggressive B-cell lymphoma. The 2016 World Health Organization (WHO) update on hematopoietic tumors suggested that all DLBCL cases should be subtyped into...

  • 4yr
    Ki67 has long been a weak prognostic factor in dlbcl. This is the first I’ve seen of subtype specific ki67 information and the first association with myc IHC positivity Show More
  • Saved

CD19 CAR-T expressing PD-1/CD28 chimeric switch receptor as a salvage therapy for DLBCL patients treated with different CD19-directed CAR T-cell therapies

CD19 CAR-T expressing PD-1/CD28 chimeric switch receptor as a salvage therapy for DLBCL patients treated with different CD19-directed CAR T-cell therapies

Source : https://jhoonline.biomedcentral.com/articles/10.1186/s13045-021-01044-y

CD19-targeted chimeric antigen receptor T (CAR T) cell therapy is a promising option to treat relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL). However, the majority of CAR T-treated patients will...

  • 4yr
    This work is somewhat preliminary but promising in that 50% of patients with a CaR enhancement achieved CR who failed prior standard CaR T ... will be interesting to continue Show More
  • Saved

ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma

ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma

Source : https://ascopubs.org/doi/full/10.1200/JCO.20.01366

PURPOSE Patients with the activated B-cell-like (ABC) subtype of diffuse large B-cell lymphoma (DLBCL) historically showed inferior survival with standard rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP). Phase II...

  • 4yr
    A disappointing result in a disease subtype that needs better therapy One can still be hopeful for better targeted therapies as the molecular mechanisms of this hererogeneous disease Show More
  • Saved

Hypomagnesemia at the time of autologous stem cell transplantation for patients with diffuse large B-cell lymphoma is associated with an increased risk of failure - PubMed

Hypomagnesemia at the time of autologous stem cell transplantation for patients with diffuse large B-cell lymphoma is associated with an increased risk of failure - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/33771971/

Magnesium is an essential element that is involved in critical metabolic pathways. A diet deficient in magnesium is associated with an increased risk of developing cancer. Few studies have reported...

  • 4yr
    Very interesting study Low mg is probably largely related to platinum use in salvage treatment. Hard to reconcile why this might lead to worse lymphoma outcomes ....
  • Saved

Overlap between EBV‐positive diffuse large B‐cell lymphoma, NOS, in a young patient and angioimmunoblastic T‐cell lymphoma: A diagnostic pitfall

Overlap between EBV‐positive diffuse large B‐cell lymphoma, NOS, in a young patient and angioimmunoblastic T‐cell lymphoma: A diagnostic pitfall

Source : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981666/

There may be significant histopathologic overlap between EBV‐positive DLBCL, NOS, and other diagnoses including angioimmunoblastic T‐cell lymphoma (AITL). Resolution of this differential diagnosis may be particularly challenging and require extensive...

  • 4yr
    I teach all of our fellows that any T cell lymphoma case should be seen by 2 different hematopathologists, with 1 being at an academic center where these cases are Show More